ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX · Real-Time Price · USD
1.630
+0.230 (16.43%)
At close: Nov 4, 2024, 4:00 PM
1.580
-0.050 (-3.07%)
Pre-market: Nov 5, 2024, 5:23 AM EST

ESSA Pharma Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 2018 - 2014
Selling, General & Admin
11.6310.8112.5412.8811.375.46
Upgrade
Research & Development
22.2521.3224.4224.2612.156.7
Upgrade
Operating Expenses
33.8832.1336.9637.1423.5212.15
Upgrade
Operating Income
-33.88-32.13-36.96-37.14-23.52-12.15
Upgrade
Interest Expense
-0-0.01-0.01-0.01-0.22-0.6
Upgrade
Interest & Investment Income
6.215.551.740.230.560.03
Upgrade
Currency Exchange Gain (Loss)
-00.010-0.02-0.040.01
Upgrade
Other Non Operating Income (Expenses)
--0.020.09-0.50
Upgrade
EBT Excluding Unusual Items
-27.67-26.58-35.22-36.84-23.73-12.72
Upgrade
Pretax Income
-27.67-26.58-35.22-36.84-23.73-12.72
Upgrade
Income Tax Expense
-0-0.11-0.03-0.290.04
Upgrade
Net Income
-27.67-26.58-35.1-36.81-23.45-12.76
Upgrade
Net Income to Common
-27.67-26.58-35.1-36.81-23.45-12.76
Upgrade
Shares Outstanding (Basic)
44444438228
Upgrade
Shares Outstanding (Diluted)
44444438228
Upgrade
Shares Change (YoY)
0.28%0.12%14.44%71.45%166.13%84.68%
Upgrade
EPS (Basic)
-0.63-0.60-0.80-0.96-1.04-1.51
Upgrade
EPS (Diluted)
-0.63-0.60-0.80-0.96-1.04-1.51
Upgrade
Free Cash Flow
-23.84-19.78-28-25.42-16.98-12.25
Upgrade
Free Cash Flow Per Share
-0.54-0.45-0.64-0.66-0.76-1.45
Upgrade
EBITDA
-----23.5-12.13
Upgrade
D&A For EBITDA
----0.020.02
Upgrade
EBIT
-33.88-32.13-36.96-37.14-23.52-12.15
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.